Source link : https://newshealth.biz/health-news/targeted-combo-plus-chemo-doubles-survival-in-braf-mutated-crc/
(MedPage Today) — CHICAGO — First-line treatment with encorafenib (Braftovi) and cetuximab (Erbitux) plus chemotherapy significantly improved survival outcomes compared with standard of care in patients with BRAF V600E-mutated metastatic colorectal… Source link : https://www.medpagetoday.com/meetingcoverage/asco/115814 Author : Publish date : 2025-05-30 12:00:00 Copyright for syndicated content belongs to the linked Source.
The post Targeted Combo Plus Chemo Doubles Survival in BRAF-Mutated CRC first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-30 12:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8